Justin Percival

Justin Percival is currently a Senior Director at Rocket Pharmaceuticals, previously serving as an Executive Director at Renovacor. Justin has a strong background in gene therapy research, particularly focused on developing treatments for neuromuscular and CNS diseases. Justin has also held positions at University of Pennsylvania, University of Miami, and University of Washington, where Justin conducted research on various aspects of muscle function and potential therapies for conditions like Duchenne muscular dystrophy. Justin holds a Ph.D. in Cell/Cellular and Molecular Biology from University of Sydney and has a Bachelor's degree in Free radical biology and Biochemistry and Molecular Biology from Victoria University of Wellington.